Sector portfolio · VC firm · United States

S32's Biotech portfolio

S32 has backed 18 Biotech startups in rounds we track, $2.4B between them, shown by the stage each has reached. The best-funded is Relay Therapeutics.

18startups backed
4stages
$2.4Braised between them
Series Abiggest stage

S32's whole portfolioS32's profile

Segment by segment

Series A

6 startups · $408M raised

  1. InceptiveInceptive is a biotechnology and artificial intelligence company founded in 2021 and based in Palo Alto, California, with additionUnited States$100M
  2. Nested TherapeuticsNested Therapeutics is a biotechnology company based in Cambridge, Massachusetts, founded in 2021.United States$90M
  3. Exai BioExai Bio is a biotechnology company based in Palo Alto, California, founded in 2021.United States$68M
  4. Parthenon TherapeuticsParthenon Therapeutics is a biotech company inventing a novel class of anti-cancer therapies that reprogram the tumor microenvironment.United States$65M
  5. ImmuneIDImmuneID is a precision immunology company.-$50M
  6. Delve BioDelve Bio is a biotechnology company based in Boston, MA, founded in 2022.United States$35M

Stage not reported

5 startups · $355M raised

  1. CelularityCelularity is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies.United States$270M
  2. TeckroTeckro is an enterprise software company founded in 2015, headquartered in Limerick, Ireland, with additional offices in Dublin anIreland$60M
  3. Sunbird BioSunbird Bio is a biotechnology company based in Cambridge, Massachusetts, with operational headquarters in Singapore.Singapore$14M
  4. TwinStrand BiosciencesTwinStrand Biosciences is a Seattle-based biotechnology company founded in 2015, focusing on Duplex SequencingTM, a highly accuratUnited States$10M
  5. Manifold BioManifold Bio is building a protein barcoding platform to bring the power of multiplexed measurement.United States$1.0M

Series B

4 startups · $358M raised

  1. MOMA TherapeuticsMOMA Therapeutics is a clinical-stage biotechnology company based in Cambridge, Massachusetts, founded in 2020.United States$150M
  2. CTCelsius TherapeuticsCelsius Therapeutics is a biotechnology company that develops precision medicines for cancer and autoimmune disease patients.United States$83M
  3. ROME TherapeuticsROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome.United States$72M
  4. AltPepAltPep is a Seattle-based biotechnology company founded in 2018 that focuses on developing early disease-modifying treatments and United States$53M

Series C and later

3 startups · $1.3B raised

  1. Relay TherapeuticsRelay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.United States$932M
  2. AlectorAlector is a biopharmaceutical company that develops therapies for the treatment of neurodegeneration diseases.United States$215M
  3. Aspen NeuroscienceAspen Neuroscience is a biotechnology company that specializes in personalized cell therapies.United States$122M

How this map is made. Every startup here works in Biotech and has raised money in a round we track that names S32 as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios

Raising from investors like S32?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.